Want to see NL:CRBN full AI Analyst Report?
CRBN Stock Chart & Stats
€19.82
-€0.03(-0.16%)
At close: 4:00 PM EDT
€19.82
-€0.03(-0.16%)
Day’s Range― - ―
52-Week Range€17.04 - €25.20
Previous CloseN/A
Volume103.79K
Average Volume (3M)132.86K
Market Cap
€1.40B
Enterprise Value€1.66B
Total Cash (Recent Filing)€36.00M
Total Debt (Recent Filing)€517.60M
Price to Earnings (P/E)22.4
Beta1.00
Next Earnings
Feb 26, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield2.64%
Share Statistics
EPS (TTM)1.08
Shares Outstanding58,250,310
10 Day Avg. Volume133,604
30 Day Avg. Volume132,859
Financial Highlights & Ratios
PEG Ratio-0.24
Price to Book (P/B)1.45
Price to Sales (P/S)0.85
P/FCF Ratio11.62
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€20.50Price Target Upside3.43% Upside
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)1.32
Revenue Forecast (FY)€1.29B
Bulls Say, Bears Say
Bulls Say
DeleveragingMaterial debt reduction has strengthened Corbion’s balance sheet and lowered financial risk relative to 2022–2023. This improves resilience through operating cycles, reduces pressure on cash resources, and preserves more flexibility for investment and capital allocation.
Positive Cash GenerationConsistently positive operating cash flow and restored free cash flow indicate improved cash discipline and an ability to fund part of the business internally. That supports financial resilience and gives Corbion greater capacity to manage obligations and sustain operations.
Improving Operating ProfitabilityHigher EBIT and EBITDA in 2025 suggest that operating profitability improved despite a softer revenue backdrop. If maintained, better operating conversion can strengthen cash generation, support deleveraging, and provide a more durable earnings base over coming quarters.
Bears Say
Multi-Year Revenue DeclineSeveral consecutive years of revenue contraction point to a challenged growth backdrop rather than a temporary quarterly fluctuation. Persistent top-line softness can limit operating leverage, reduce reinvestment capacity, and make future earnings improvement more dependent on efficiency.
Uneven Net IncomeLarge differences in net-income performance across recent years reduce confidence in earnings durability and visibility. Uneven bottom-line conversion can complicate capital planning, weaken the reliability of retained cash, and make reported profitability more sensitive to individual-year effects.
Reduced Asset BaseThe reduction in total assets indicates a smaller balance-sheet base supporting Corbion’s operations than in 2023. While deleveraging is positive, a shrinking asset base may constrain scale and productive capacity, making sustained operating improvement more important.
Corbion NV News
CRBN FAQ
What was Corbion NV’s price range in the past 12 months?
Corbion NV lowest stock price was €17.04 and its highest was €25.20 in the past 12 months.
What is Corbion NV’s market cap?
Corbion NV’s market cap is €1.40B.
When is Corbion NV’s upcoming earnings report date?
Corbion NV’s upcoming earnings report date is Feb 26, 2027 which is in 126 days.
How were Corbion NV’s earnings last quarter?
Corbion NV released its earnings results on Jul 31, 2026. The company reported €0.51 earnings per share for the quarter, beating the consensus estimate of €0.49 by €0.02.
Is Corbion NV overvalued?
According to Wall Street analysts Corbion NV’s price is currently Undervalued.
Does Corbion NV pay dividends?
Corbion NV pays a Notavailable dividend of €1 which represents an annual dividend yield of 2.64%. See more information on Corbion NV dividends here
What is Corbion NV’s EPS estimate?
Corbion NV’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Corbion NV have?
Corbion NV has 58,250,310 shares outstanding.
What happened to Corbion NV’s price movement after its last earnings report?
Corbion NV reported an EPS of €0.51 in its last earnings report, beating expectations of €0.49. Following the earnings report the stock price went down -2.923%.
Which hedge fund is a major shareholder of Corbion NV?
Currently, no hedge funds are holding shares in NL:CRBN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Corbion NV
Corbion NV engages in the development, production, sale, and distribution of ingredients for food and biochemicals. It operates through the following segments: Food and Biochemicals. The Food segment provides biobased ingredients for the food industry. The Biochemicals segment produces chemicals derived from organic acids through the fermentation of carbohydrates, and lactic acid based solutions. The company was founded on August 21, 1919 and is headquartered in Amsterdam, the Netherlands.
CRBN Stock 12 Month Forecast
Average Price Target
€20.50
▲(3.43% Upside)